New Delhi, Aug 30 (Ians) Digital healthcare platform MediBuddy on Wednesday said it has secured additional funding of $18 million from existing investors Quadria Capital, Lightrock and TEAMFund.
In February 2022, MediBuddy raised $125 million during the Series C funding.
The additional funding, said the company, will put it in a solid position to navigate the current landscape and achieve its ambitious growth targets over the next three years, driving strategic acquisitions and continued expansion.
“MediBuddy’s growth trajectory has consistently achieved a Compound Annual Growth Rate (Cagr) of 95.5 per cent over the past three years. The additional funds will be critical in driving our strategic acquisition initiatives, further expanding our reach, and enhancing the depth and breadth of our services,” said Satish Kannan, Co-Founder and CEO of MediBuddy.
Two of MediBuddy’s recent strategic acquisitions, such as Clinix, an online medical consultation platform focusing on rural India, and US-based Aetna Inc’s vHealth...
In February 2022, MediBuddy raised $125 million during the Series C funding.
The additional funding, said the company, will put it in a solid position to navigate the current landscape and achieve its ambitious growth targets over the next three years, driving strategic acquisitions and continued expansion.
“MediBuddy’s growth trajectory has consistently achieved a Compound Annual Growth Rate (Cagr) of 95.5 per cent over the past three years. The additional funds will be critical in driving our strategic acquisition initiatives, further expanding our reach, and enhancing the depth and breadth of our services,” said Satish Kannan, Co-Founder and CEO of MediBuddy.
Two of MediBuddy’s recent strategic acquisitions, such as Clinix, an online medical consultation platform focusing on rural India, and US-based Aetna Inc’s vHealth...
- 8/30/2023
- by Agency News Desk
- GlamSham
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.